Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:valsartan
gptkb:amlodipine |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2007 |
| gptkbp:ATCCode |
C09DB01
|
| gptkbp:contraindication |
pregnancy
severe hepatic impairment hypersensitivity to components |
| gptkbp:drugClass |
antihypertensive
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exforge
|
| gptkbp:indication |
patients not adequately controlled on monotherapy
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
calcium channel blocker and angiotensin II receptor antagonist combination
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
edema
dizziness headache |
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|